Bayer

Endocrinology

Primary Care

Cardiology

Nephrology

Rajiv Agarwal is a tenured Professor of Medicine at Indiana University School of Medicine at Indianapolis, Indiana.  


Professor Agarwal earned his medical degree from the All India Institute of Medical Sciences in New Delhi and completed his residency in internal medicine and nephrology at the University of Texas, Southwestern Dallas. 



In July 1997, he joined Indiana University as Clinical Assistant Professor, later promoted to Professor of Medicine, receiving the Indiana University Trustee's teaching award and the Young Scholar award of the American Society of Hypertension. Professor Agarwal is an internationally recognized leader in the area of hypertension in patients receiving hemodialysis and has been continuously funded for randomized trials since 2003 by the National Institutes of Health.

Professor Rajiv Agarwal

Mikhail Kosiborod is a cardiologist, the Vice-President of Research at Saint Luke’s Health System, Executive Director of the Cardiometabolic Center Alliance, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, Professor of Medicine at the University of Missouri-Kansas City School of Medicine, and the inaugural recipient of the Ben McCallister, MD Endowed Chair in Cardiovascular Research at Saint Luke’s Health System.


Professor Kosiborod is an internationally recognized expert in the field of cardiometabolic disease and has authored and co-authored more than 400 peer-reviewed publications. Professor Kosiborod has conducted and led numerous national and international clinical trials; many of which have had a significant impact on treatment guidelines and clinical practice. Professor Kosiborod’s body of work has been central to the elucidation of the impact of sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in improving cardiovascular outcomes and survival in various clinical settings, perhaps some of the most important advances in clinical cardiology seen in a generation.

Professor Mikhail Kosiborod

Luiza Caramori graduated top of her class in medical school at the Universidade Federal do Rio Grande do Sul in Brazil and completed a residency in internal medicine, followed by a clinical fellowship in paediatric and adult endocrinology. She then completed a MSc and subsequently obtained her PhD. Dr Caramori was a research and clinical fellow in paediatric nephrology (1998–2002) and endocrinology and diabetes (2004–2006) at the University of Minnesota, respectively.


She joined the faculty at the University of Minnesota in 2006 and is currently an Adjunct Associate Professor in the Department of Medicine. She joined the Cleveland Clinic Foundation in 2022 and she is Staff Physician at the Endocrinology and Metabolism Institute. Dr Caramori has authored numerous original manuscripts and book chapters, and has received multiple awards for her work in research and her post-doctoral fellowship. 


She has been the principal investigator on NIH and JDRF awards and the centre principal investigator on a number of clinical trials in patients with diabetic kidney disease and other diabetes-related complications. Additionally, she is the past-Chair of the American Diabetes Association diabetic nephropathy subcommittee and a member of the Kidney Disease: Improving Global Outcomes (KDIGO) task force.

Meet our experts

Medical specialties